CD4+ CD25+CD127dimFoxp3+ T cells are cytotoxic for human neurons

Journal of Leukocyte Biology

Volumn 89, Issue 6, 2011, Pages 927-934

  Haile, Yohannes ^a   Pasychniyk, Dion ^a   Turner, Diane ^a   Bleackley, R Chris ^a   Giuliani, Fabrizio ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Axonal injury; Cytotoxicity; Granzyme B; Neurodegeneration

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 7 RECEPTOR; MEMBRANE PROTEIN; PROTEIN GRB; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; IL2RA PROTEIN, HUMAN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA; MESSENGER RNA;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CELL SUBPOPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NERVE CELL; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; APOPTOSIS; CD4+ T LYMPHOCYTE; CELL CULTURE; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY;

EID: 79957818200     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1210654     Document Type: Article

References (43)

1. Brown, K, Wong, W. (2008) Diagnostic value of regulatory T cells: a new facet of a much studied cell population. Transplantation 86, 1485-1491.
2. Galea, I., Bechmann, I., Perry, V. H. (2007) What is immune privilege (not)? Trends Immunol. 28, 12-18.
3. Hauser, S. L., Oksenberg, J. R. (2006) The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52, 61-76.
4. Correale, J., Villa, A. (2007) The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting. Autoimmunity 40, 148-160.
5. Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R, Mork, S., Bo, L. (1998) Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338, 278-285.
6. McFarland, H. F., Martin, R (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8, 913-919.
7. Lassmann, H., Bruck, W., Lucchinetti, C. F. (2007) The immunopathol-ogy of multiple sclerosis: an overview. Brain Pathol. 17, 210-218.
8. Bitsch, A., Schuchardt, J., Bunkowski, S., Kuhlmann, T., Brück, W. (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123, 1174-1183.
9. Shriver, L. P., Dittel, B. N. (2006) T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis. Am. J. Pathol. 169, 999-1011.
10. Compston, A, Coles, A. (2002) Multiple sclerosis. Lancet 359, 1221-1231.
11. Giuliani, F., Goodyer, C. G., Antel, J. P., Yong, V. W. (2003) Vulnerability of human neurons to T cell-mediated cytotoxicity. J. Immunol. 171, 368-379.
12. Neumann, H., Medana, I. M., Bauer, J., Lassmann, H. (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neu-rosci. 25, 313-319.
13. Wang, T., Allie, R, Conant, K, Haughey, N., Turchan-Chelowo, H., Hahn, K, Rosen, A, Steiner, J., Keswani, S., Jones, M., Calabresi, P. A, Nath, A. (2006) Granzyme B mediates neurotoxicity through a G-protein-coupled receptor. FASEB J. 20, 1209-1211.
14. Giuliani, F., Yong, V. W. (2003) Immune-mediated neurodegeneration and neuroprotection in MS. Int. MS J. 10, 122-130.
15. Malmestrom, C, Lycke, J., Haghighi, S., Andersen, O., Carlsson, L., Wadenvik, H., Olsson, B. (2008) Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF. J. Neuroim-munol. 196, 159-165.
16. Von Boehmer, H. (2005) Mechanisms of suppression by suppressor T cells. Nat. Immunol. 6, 338-344.
17. Liesz, A, Suri-Payer, E., Veltkamp, C, Doerr, H., Sommer, C, Rivest, S., Giese, T., Veltkamp, R (2009) Regulatory T cells are key cerebroprotec-tive immunomodulators in acute experimental stroke. Nat. Med. 15, 192-199.
18. Kohm, A. P., Carpentier, P. A, Anger, H. A., Miller, S. D. (2002) Cutting edge: CD4 + CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169, 4712-4716.
19. Kipnis, J., Avidan, H., Caspi, R R, Schwartz, M. (2004) Dual effect of CD4 + CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia. Proc. Natl. Acad. Sci. USA 101 (Suppl. 2), 14663-14669.
20. Miyara, M., Yoshioka, Y, Kitoh, A, Shima, T., Wing, K, Niwa, A, Parizot, C, Taflin, C, Heike, T., Valeyre, D., et al. (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30, 899-911.
21. Kerkovich, D. M., Sapp, D., Weidenheim, K., Brosnan, C. F., Pfeiffer, S. E., Yeh, H. H., Busciglio, J. (1999) Fetal human cortical neurons grown in culture: morphological differentiation, biochemical correlates and development of electrical activity. Int. J. Dev. Neurosci. 17, 347-356.
22. Rosenstein, J. M. (1995) Diminished expression of microtubule-associated protein (MAP-2) and /3-tubulin as a putative marker for ischemic injury in neocortical transplants. Cell Transplant. 4, 83-91.
23. Chaitanya, G. V., Kolli, M., Babu, P. P. (2009) Granzyme-B mediated cell death in the spinal cord-injured rat model. Neuropathology 29, 270-279.
24. Kroner, A, Ip, C. W., Thalhammer, J., Nave, K. A, Martini, R (2010) Ectopic T-cell specificity and absence of perforin and granzyme B alleviate neural damage in oligodendrocyte mutant mice. Am. J. Pathol. 176, 549-555.
25. Buckner, J. H. (2010) Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat. Rev. Immunol. 10, 849-859.
26. Walker, M. R, Kasprowicz, D. J., Gersuk, V H., Bernard, A, Van Lan- deghen, B., Buckner, J. H., Ziegler, S. F. (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4 + CD25- T cells. J. Clin. Invest. 112, 1437-1443.
27. Hori, S., Nomura, T., Sakaguchi, S. (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061.
28. Fontenot, J. D., Gavin, M. A., Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat. Immunol. 4, 330-336.
29. Grossman, W. J., Verbsky, J. W., Barchet, W., Colonna, M., Atkinson, J. P., Ley, T. J. (2004) Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21, 589-601.
30. Vignali, D. (2008) How many mechanisms do regulatory T cells need? Eur. J. Immunol. 38, 908-911.
31. Liu, W., Putnam, A. L., Xu-Yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., Fazekas de St Groth, B., Clay-berger, C, Soper, D. M., Ziegler, S. F., Bluestone, J. A. (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 203, 1701-1711.
32. Zhu, J., Paul, W. E. (2010) CD4+ T cell plasticity-Th2 cells join the crowd. Immunity 32, 11-13.
33. Koenen, H. J., Smeets, R L., Vink, P. M., van Rijssen, E., Boots, A. M., Joosten, I. (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112, 2340-2352.
34. Kebir, H., Kreymborg, K, Ifergan, I., Dodelet-Devillers, A., Cayrol, R, Bernard, M., Giuliani, F., Arbour, N., Becher, B., Prat, A. (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 13, 1173-1175.
35. Wang, T., Lee, M. H., Johnson, T., Allie, R, Hu, L., Calabresi, P. A, Nath, A. (2010) Activated T-cells inhibit neurogenesis by releasing gran-zyme B: rescue by kv1.3 blockers. J. Neurosci. 30, 5020-5027.
36. Cao, X., Cai, S. F., Fehniger, T. A, Song, J., Collins, L. I., Piwnica-Worms, D. R, Ley, T. J. (2007) Granzyme B and perforin are important for regu-latory T cell-mediated suppression of tumor clearance. Immunity 27, 635-646.
37. Gondek, D. C, Lu, L. F., Quezada, S. A, Sakaguchi, S., Noelle, R. J. (2005) Cutting edge: contact-mediated suppression by CD4 + CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 174, 1783-1786.
38. Henkart, P. A. (1985) Mechanism of lymphocyte-mediated cytotoxicity. Annu. Rev. Immunol. 3, 31-58.
39. Vignali, D. A, Collison, L. W., Workman, C. J. (2008) How regulatory T cells work. Nat. Rev. Immunol. 8, 523-532.
40. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C, Martínez-Llordella, M., Ashby, M., Nakayama, M., Rosenthal, W., Bluestone, J. A (2009) Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10, 1000-1007.
41. Zhou, X., Bailey-Bucktrout, S., Jeker, L. T., Bluestone, J. A. (2009) Plasticity of CD4(+) FoxP3(+) T cells. Curr. Opin. Immunol. 21, 281-285.
42. Osorio, F., LeibundGut-Landmann, S., Lochner, M., Lahl, K, Sparwasser, T., Eberl, G., Reis e Sousa, C. (2008) DC activated via dectin-1 convert Treg into IL-17 producers. Eur. J. Immunol. 38, 3274-3281.
43. Korn, T., Reddy, J., Gao, W., Bettelli, E, Awasthi, A, Petersen, T. R, Backstrom, B. T., Sobel, R A, Wucherpfennig, K. W., Strom, T. B., Oukka, M., Kuchroo, V. K (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13, 423-431.